- Filed
- Nov 21, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2024 | 3.63M sh |
| Long Term Debt | Q3 2025 · Oct 31, 2024 | $41K |
| Long Term Debt | Q3 2025 · Jan 31, 2024 | $41K |
| Current Liabilities | Q3 2025 · Oct 31, 2024 | $11.46K |
| Current Liabilities | Q3 2025 · Jan 31, 2024 | $8.38K |
| Total Liabilities | Q3 2025 · Oct 31, 2024 | $95.42K |
| Total Liabilities | Q3 2025 · Jan 31, 2024 | $69.02K |
| Current Assets | Q3 2025 · Oct 31, 2024 | $71 |
| Current Assets | Q3 2025 · Jan 31, 2024 | $4.51K |
| Total Assets | Q3 2025 · Oct 31, 2024 | $30.47K |
| Total Assets | Q3 2025 · Jan 31, 2024 | $28.76K |
| Net Income | Q3 2025 · Jan 31, 2024 | −$40.25K |
| Net Income | Q3 2025 · Oct 31, 2023 | −$4.46K |
| Net Income | Q3 2025 · Oct 31, 2023 | −$39.47K |
| Net Income | Q3 2025 · Jan 31, 2023 | −$22.19K |
| Net Income restated | Q3 2025 · Jan 31, 2022 | −$731 |
| Shares Diluted | Q3 2025 · Oct 31, 2023 | 3.63M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2023 | 3.61M sh |
| Operating Cash Flow | Q3 2025 · Oct 31, 2023 | −$31.69K |
| Cash And Equivalents | Q3 2025 · Oct 31, 2023 | $2.15K |
| Cash And Equivalents | Q3 2025 · Jan 31, 2023 | $23.07K |
| Eps Diluted | Q3 2025 · Oct 31, 2023 | $0.00 |
| Eps Diluted | Q3 2025 · Oct 31, 2023 | $0.00 |
| Eps Basic | Q3 2025 · Oct 31, 2023 | $0.00 |
| Eps Basic | Q3 2025 · Oct 31, 2023 | $0.00 |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $8.06K |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $43.07K |
| Revenue | Q3 2025 · Oct 31, 2023 | $3.6K |
| Revenue | Q3 2025 · Oct 31, 2023 | $3.6K |
| Stockholders Equity | Q3 2025 · Jan 31, 2023 | −$1.32K |
| Stockholders Equity | Q3 2025 · Jan 31, 2022 | −$481 |
| Stockholders Equity | Q3 2025 · Jan 9, 2022 | $0 |